A specialty pharmaceutical company commercializing ZECUITY® sumatriptan iontophoretic transdermal system (patch) for the acute treatment of migraine. In February 2014, NuPathe was acquired by Teva Pharmaceutical Industries.
A specialty pharmaceutical company commercializing ZECUITY® sumatriptan iontophoretic transdermal system (patch) for the acute treatment of migraine. In February 2014, NuPathe was acquired by Teva Pharmaceutical Industries.